EE60 Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England
Abstract
Authors
Mafalda Ramos Sara Larsen Francesco Fusco Mark Lamotte Matthew Capehorn